V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260018649 | 260009014 | 1.81 | 63.5 | Curative (C) | 2016-12-18 | 2017-06-06 | Carboplatin AUC 6 - 10 | 1 | N | 260026959 | CARBOPLATIN |
| 260018650 | 260009024 | 1.59 | 70 | Curative (C) | 2017-01-10 | 2017-01-10 | CISPLATIN + ETOPOSIDE | N | N | 260026973 | CISPLATIN + ETOPOSIDE |
| 260018651 | 260016831 | null | 48.3 | Curative (C) | 2017-04-07 | 2018-02-10 | LEAM | N | N | 260026990 | LEAM |
| 260018652 | 260009037 | null | 101.999 | Curative (C) | 2014-06-09 | 2014-06-28 | Methotrexate intrathecal | 2 | N | 260026993 | METHOTREXATE INTRATHECAL |
| 260018653 | 260009039 | 1.68 | 102.5 | Curative (C) | 2013-07-23 | 2013-08-23 | null | N | N | 260027000 | NOT MATCHED |
| 260018654 | 260016838 | 1.79 | 90 | null | 2015-01-21 | 2015-01-22 | ETOPOSIDE | 01 | N | 260027066 | ETOPOSIDE |
| 260018655 | 260009071 | 1.81 | 73.2 | Palliative (P) | 2016-11-01 | 2016-12-03 | GALLIUM TRIAL | N | N | 260027092 | GALLIUM TRIAL |
| 260018656 | 260009080 | null | 79.5 | Curative (C) | 2017-10-24 | 2017-11-08 | BEAM | 02 | N | 260027107 | LEAM |
| 260018657 | 260009084 | 1.84 | 96.7 | Curative (C) | 2014-04-15 | 2014-04-15 | BENDAMUSTINE | N | N | 260027110 | BENDAMUSTINE |
| 260018658 | 260009091 | null | 102.5 | Palliative (P) | 2014-06-14 | 2014-10-17 | Carboplatin AUC 6 - 10 | N | N | 260027118 | CARBOPLATIN |
| 260018659 | 260014331 | 1.55 | 89.7 | Disease modification (D) | 2018-05-10 | 2018-05-11 | Trial Unspecified | N | N | 260027129 | TRIAL |
| 260018660 | 260009107 | 1.69 | 94 | Curative (C) | 2018-01-29 | 2018-03-02 | null | N | N | 260027155 | NOT MATCHED |
| 260018661 | 260009110 | 1.8 | 68.6 | Palliative (P) | 2017-03-20 | 2017-03-20 | TIP | 2 | N | 260027161 | TIP |
| 260018662 | 260009113 | 1.79 | 77.3 | null | 2018-04-12 | 2018-04-30 | ETOPOSIDE | N | N | 260027164 | ETOPOSIDE |
| 260018663 | 260009116 | 1.84 | 79.5 | Curative (C) | 2015-03-27 | 2016-05-26 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + FILGRASTIM + METHOTREXATE | N | N | 260027176 | NOT MATCHED |
| 260018664 | 260016856 | 1.6 | null | Curative (C) | null | 2018-08-22 | Bendamustine + prednisolone | null | null | 260027200 | BENDAMUSTINE |
| 260018665 | 260009140 | 1.76 | null | Palliative (P) | 2014-08-30 | 2014-09-01 | Trial Unspecified | Y | N | 260027220 | TRIAL |
| 260018666 | 260009144 | null | null | Disease modification (D) | 2015-04-06 | 2015-04-09 | PACIFICO TRIAL | 02 | N | 260027222 | PACIFICO TRIAL |
| 260018667 | 260014360 | null | 84 | Curative (C) | 2015-10-17 | 2015-10-17 | TIP | Y | N | 260027225 | TIP |
| 260018668 | 260009154 | 1.57 | 74.6 | Curative (C) | 2018-06-25 | 2018-08-29 | PACIFICO TRIAL | 02 | null | 260027234 | PACIFICO TRIAL |
| 260018669 | 260009163 | 1.78 | null | Palliative (P) | 2017-07-01 | 2017-07-08 | Cisplatin + Etoposide (5 day) | 2 | N | 260027266 | CISPLATIN + ETOPOSIDE |
| 260018670 | 260014366 | 1.83 | 101.299 | Disease modification (D) | 2019-06-12 | 2019-06-17 | Methotrexate intrathecal | 02 | N | 260027267 | METHOTREXATE INTRATHECAL |
| 260018671 | 260018746 | null | 65.7 | Not known (9) | null | 2017-05-14 | Methotrexate intrathecal | null | null | 260027286 | METHOTREXATE INTRATHECAL |
| 260018672 | 260014372 | 1.67 | 84.4 | Curative (C) | 2015-11-05 | 2015-11-08 | null | 1 | N | 260027294 | NOT MATCHED |
| 260018673 | 260009182 | 1.78 | 89 | null | 2017-03-28 | 2017-03-30 | ETOPOSIDE | 2 | N | 260027332 | ETOPOSIDE |
| 260018674 | 260014381 | 1.62 | null | Curative (C) | 2014-08-21 | 2014-11-21 | ICE-R (Cycle 2 onwards) | 1 | Y | 260027337 | LEAM |
| 260018675 | 260009208 | 1.75 | 89.3 | null | 2017-07-26 | 2017-09-17 | BENDAMUSTINE | N | N | 260027391 | BENDAMUSTINE |
| 260018676 | 260009211 | null | 84.5 | Curative (C) | 2019-04-02 | 2019-04-03 | TIP | N | null | 260027407 | TIP |
| 260018677 | 260014394 | null | null | Curative (C) | 2016-04-13 | 2016-05-02 | Carboplatin AUC 6 - 10 | N | N | 260027411 | CARBOPLATIN |
| 260018678 | 260018129 | null | 130 | Palliative (P) | 2014-10-14 | 2015-01-07 | Obinutuzumab + CVP | N | N | 260027472 | NOT MATCHED |
| 260018679 | 260019086 | 1.52 | 86 | Curative (C) | 2017-05-06 | 2017-12-03 | Trial Unspecified | 01 | N | 260027487 | TRIAL |
| 260018680 | 260014403 | 1.69 | 127 | null | 2019-02-03 | 2019-02-04 | Methotrexate intrathecal | 2 | N | 260027502 | METHOTREXATE INTRATHECAL |
| 260018681 | 260009249 | 1.88 | 53.5 | Curative (C) | 2014-01-28 | 2014-03-24 | TIP | N | N | 260027617 | TIP |
| 260018682 | 260009251 | null | 0 | Disease modification (D) | 2013-08-24 | 2013-11-03 | BEAM | N | N | 260027639 | ICE-R |
| 260018683 | 260009259 | null | 28 | Curative (C) | 2018-03-26 | 2018-06-26 | LEAM | Y | N | 260027689 | BEAM |
| 260018684 | 260009265 | 1.62 | 61 | Palliative (P) | 2019-01-16 | 2019-01-23 | PACIFICO TRIAL | 02 | N | 260027731 | PACIFICO TRIAL |
| 260018685 | 260009270 | 1.64 | 93 | null | 2018-10-18 | 2018-10-31 | Methotrexate intrathecal | Y | N | 260027764 | METHOTREXATE INTRATHECAL |
| 260018686 | 260009303 | 1.75 | 75 | Curative (C) | 2015-02-13 | 2015-02-16 | TIP | 02 | N | 260027954 | TIP |
| 260018687 | 260009309 | null | 67.35 | Curative (C) | 2017-09-04 | 2017-09-09 | BEAM | null | null | 260027957 | BEAM |
| 260018688 | 260009312 | 1.75 | 109.8 | Disease modification (D) | null | 2017-11-28 | TIP | 2 | N | 260027968 | TIP |
| 260018689 | 260009315 | 1.78 | null | Curative (C) | 2013-12-28 | 2014-03-07 | Carboplatin AUC 6 - 10 | 02 | N | 260027974 | CARBOPLATIN |
| 260018690 | 260018146 | 1.67 | 90 | Palliative (P) | 2014-01-14 | 2014-03-22 | Cisplatin + Etoposide (3 day) | N | null | 260028031 | CISPLATIN + ETOPOSIDE |
| 260018691 | 260009331 | 1.87 | 66.3 | Curative (C) | 2016-03-30 | 2016-03-30 | null | N | N | 260028059 | NOT MATCHED |
| 260018692 | 260009360 | 1.67 | 101 | Palliative (P) | 2018-07-13 | 2018-07-19 | DHAP - R | 02 | N | 260028213 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260018693 | 260009364 | 1.76 | 101 | Adjuvant (A) | 2019-01-30 | 2019-04-11 | CTD Attenuated (Thalidomide 100mg) | 02 | Y | 260028229 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260018694 | 260009377 | null | 72.4 | Disease modification (D) | 2014-08-03 | 2014-08-06 | PAC-PLAT | N | N | 260028277 | VINBLASTINE |
| 260018696 | 260009387 | 1.94 | 138.2 | Palliative (P) | 2019-05-01 | 2019-05-01 | CYCLOPHOSPHAMIDE | N | N | 260028301 | GEMCITABINE |
| 260018697 | 260009393 | 1.8 | 93.5 | Curative (C) | 2017-06-17 | 2017-07-04 | CISPLATIN + GEMCITABINE | N | N | 260028305 | R CODOX-M/ R IVAC |
| 260018698 | 260009395 | 1.71 | null | Disease modification (D) | 2017-12-29 | 2017-12-29 | Cisplatin + Radiotherapy | 2 | N | 260028311 | DHAP |
| 260018699 | 260009399 | 1.68 | null | Disease modification (D) | 2018-12-31 | 2019-01-08 | Radium 223 | 2 | N | 260028315 | R IVAC |